Celularity Inc (CELU)
Healthcare
Biotechnology
0.66 $
+3.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Celularity Inc (CELU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 107 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 246 | 157 | 157 | 144 | 144 | 129 | 133 | 133 | 120 | 114 | 107 | 107 | |
| 18 | 16 | 16 | 23 | 20 | 15 | 21 | 21 | 17 | 11 | 12 | 12 | |
| 3.1 | 0.3 | 0.3 | 1.9 | 0.2 | 0.1 | 0.7 | 0.7 | 0.9 | 0.1 | 6.2 | 6.2 | |
| 3.1 | – | 0.3 | – | 0.2 | 0.1 | – | 0.7 | 0.9 | 0.1 | – | 6.2 | |
| 4.9 | 4.1 | 6.2 | 14 | 12 | 8.8 | 14 | 14 | 11 | 6.7 | 4.7 | 4.7 | |
| 5.7 | 4.9 | 4.9 | 3.7 | 5.8 | 4.0 | 5.4 | 5.4 | 4.4 | 2.6 | 0.6 | 0.6 | |
| 86 | – | – | – | – | – | – | – | – | – | – | – | |
| 90 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 | |
| 12 | 12 | 12 | 10 | 11 | 9.6 | 9.2 | 9.2 | 8.5 | 8.1 | 7.8 | 7.8 | |
| 128 | 127 | 127 | 113 | 103 | 112 | 124 | 124 | 146 | 134 | 145 | 145 | |
| 65 | 85 | 85 | 66 | 67 | 76 | 54 | 54 | 69 | 65 | 81 | 81 | |
| 17 | – | 35 | – | 39 | 43 | – | 6.4 | 6.9 | 5.7 | – | 14 | |
| 12 | 13 | 13 | 13 | 14 | 15 | 23 | 23 | 24 | 25 | 26 | 26 | |
| 17 | – | – | – | – | – | 36 | 36 | 36 | – | – | – | |
| 119 | 30 | 30 | 31 | 41 | 17 | 8.8 | 8.8 | -25 | -20 | -38 | -38 | |
| -757 | -851 | -851 | -864 | -842 | -886 | -900 | -900 | -944 | -967 | -991 | -991 | |
| 18 | 19 | 19 | 22 | 19 | 22 | 23 | 22 | 24 | 26 | 29 | 26 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.